Spatial Omics Solutions Market worth $587.2 Million by 2030 - Exclusive Report by InsightAce Analytic
JERSEY CITY, N.J., Aug. 10, 2022 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Spatial Omics Solutions Market By Solution Type (Instruments, Consumables And Services), Sample Analyzed (DNA, RNA, And Protein Samples), Application (Diagnosis, Translation Research, Drug Discovery And Development, Single Cell Analysis, Cell Biology And Other Applications), End-User Segment (Academic And Research Institutions, Biopharmaceutical And Biotechnological Companies, Contract Research Organizations And Other)- Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
According to the latest research by InsightAce Analytic, the global spatial omics solutions market is valued at US$ 232.6 million in 2021, and it is expected to reach US$ 587.2 million by 2030, with a CAGR of 11.18% during the forecast period of 2022-2030.
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1352
The phrase "spatial omics" refers to a group of technologies that allow -omics data to be superimposed on images of tissue. There are several different types of omics studies that are all grouped under the umbrella word "omics." As an example, genomics examines the entire genome, transcriptomics reads the RNA, and proteomics studies the protein content. Decoding the primary sequence of genes has been shifted to assessing the position and interaction of cell types and biomarkers (namely, DNA/RNA/Protein) through the spatial phenotyping method. Next-generation sequencing (NGS) methods can easily incorporate spatial phenotyping systems. As a result, innovative gadgets are increasingly being used to move research from the discovery stage all the way to the translational and clinical stages. There has been substantial progress in the field of omics-based analysis. The developers of spatial-omics solutions are working hard to increase the penetration of their unique technologies into a wide range of clients, including academic research centres, research institutions, and biopharmaceutical firms. As a consequence of this, they are working on introducing more complex features into their products. These features include high-multiplexing, automated sample processing, biomarker-specific gene panels, and image analysis based on machine learning.
The rising prevalence of various types of genetic disorders, advances in sequencing technology on a global scale, and an increase in funding for spatial omics research are all factors driving the market. This novel technique offers an opportunity to better understand the mechanisms that govern the specific cell interactions at the tumour boundary, which is extremely helpful in the early detection of malignancy. In addition, new advanced devices launched by medical device manufacturers will be responsible for the increase in research into spatial OMICS' potential as a cancer diagnosis tool, which will, in turn, help to fuel the market's expansion. The growing use of spatial genomics and transcriptomics for drug development and biomarker identification is also projected to drive market revenue growth over the forecast period.
However, The lack of computational analytical tools and the high capital investment necessary for international expansion are two market limitations. Additionally, a slow technical advancement rate may impede the market's growth for spatial omics solutions.
North America currently holds the highest portion of the global market for spatial omics solutions due to improvements in healthcare infrastructure, rises in per capita income, and the existence of advanced research institutes and laboratories.
The prominent and exclusive market player lst includes Fluidigm Corporation, 10x Genomics, Inc., Bruker, Canopy Biosciences, NanoString Technologies, Inc., Bio-Techne Corporation, Flagship Biosciences, Inc, Akoya Biosciences, Inc., Rebus Biosystems, BioSpyder Technologies, S2 Genomics, Inc., IONpath, Inc., Miltenyi Biotec, RareCyte, Inc., Visikol, Inc., Illumina Inc., Bio-Rad Laboratories, Inc., Fluidigm Corporation, Genomic Vision, Seven Bridges Genomics, Resolve Biosciences, Readcoor, Inc., Lunaphore Technologies, Molecular Machines & Industries (MMI), Dovetail Genomics, Vizgen Corp., Optical Biosystems, Inc., Ultivue, Inc., Cytiva and other vital companies
For More Information @ https://www.insightaceanalytic.com/customisation/1352
Key developments in the market
Global Spatial Omics Solutions Market, by Solution Type, 2022-2030 (Value US$ Mn)
Global Spatial Omics Solutions Market, by Sample Analyzed, 2022-2030 (Value US$ Mn)
Global Spatial Omics Solutions Market, by Application, 2022-2030 (Value US$ Mn)
Global Spatial Omics Solutions Market, by End-User, 2022-2030 (Value US$ Mn)
Global Spatial Omics Solutions Market, by Region, 2022-2030 (Value US$ Mn)
North America Spatial Omics Solutions Market, by Country, 2022-2030 (Value US$ Mn)
Europe Spatial Omics Solutions Market, by Country, 2022-2030 (Value US$ Mn)
Asia Pacific Spatial Omics Solutions Market, by Country, 2022-2030 (Value US$ Mn)
Latin America Spatial Omics Solutions Market, by Country, 2022-2030 (Value US$ Mn)
Middle East & Africa Spatial Omics Solutions Market, by Country, 2022-2030 (Value US$ Mn)
Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1352
Why should buy this report:
Other Related Reports Published by InsightAce Analytic:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.